Last reviewed · How we verify
A Pilot Study for Collection of High-Titer Anti-Influenza A Plasma
Treatment options are limited for the treatment of influenza. This study will collect blood from people who have been exposed to the influenza virus or who have received a seasonal influenza vaccine. The blood plasma will be used in a future clinical trial to treat people hospitalized with influenza.
Details
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| Status | COMPLETED |
| Enrolment | 21 |
| Start date | 2010-04 |
| Completion | 2019-01-04 |
Conditions
- Influenza A Virus Infection
Interventions
- Collection of Anti-Influenza A Immune Plasma
Primary outcomes
- Collection of high antibody titer anti-influenza FFP — Collected at each study visit
Countries
United States